The purpose of this study was to conduct a qualitative analysis of decision-making control by men with prostate cancer who refuse conventional cancer therapies. The transcripts for 8 prostate cancer patients from a larger qualitative study were analyzed separately to explore in depth the factors related to decision-making control. Results. Most men were newly diagnosed when they made the decision to forgo conventional cancer treatment in favor of alternative approaches. Five areas were identified in which patients took control over the treatment process. These include control over (1) the timing of treatment, (2) information about conventional treatment and risk assessment, (3) designing an alternative treatment plan, (4) coordination of cancer care, and (5) monitoring and evaluation of disease progression. Clinicians can support patients who delay or forgo treatment for prostate cancer by helping them maintain a sense of control over the treatment process. This can be achieved by supporting patients' efforts to integrate complementary therapies into their cancer care, by addressing fears related to treatment early in the decision-making process, and by encouraging open communication about the reasons for seeking alternatives to conventional treatment. Findings from this study need to be evaluated in a larger, quantitative study.
The use of complementary and alternative medicine (CAM) by men with prostate cancer has become increasingly popular in recent years. A Canadian survey of 451 men with prostate cancer reported that 39% had used CAM and 30% of these started using CAM after their diagnosis of prostate cancer. 1 A US study of 1099 prostate patients reported that 23.5% of patients had previously used CAM (limited to nutritional interventions) and 18.2% were currently using these therapies. 2 As the popularity of CAM increases, there is a parallel increase in the number of patients making the decision to forgo conventional cancer treatment. A Canadian study found that 9% of patients refused one or more cancer treatments. British Columbia proportionally had the highest number of patients refusing treatment (13%). 3 Although little is known about why and when patients decide to forgo conventional treatment, Simmons and Lindsey 4 reported that 13% of the cancer patients rejected treatment at the outset, often prior to their first visit to a cancer center. Feldman-Stewart et al 5 found in their survey of men with earlystage prostate cancer that 6 of the 10 questions patients said were most essential to have answered relate to the consequences of delaying or having no conventional treatment. Prostate cancer has the highest incidence rate and the second highest death rate of all cancer types for men. 6 Therefore, even a small percentage of patients refusing treatment could affect a significant number of men with prostate cancer.
Current evidence suggests that sense of control may be an important factor influencing the decision to use CAM and to refuse conventional cancer treatment. The need to maintain a sense of control in response to the diagnosis of a life-threatening illness was reported as one of the main reasons for using CAM in a Canadian survey of men with prostate cancer. 1 Wilkinson et al 2 concluded that CAM use improved emotional wellbeing, as men with prostate cancer reported feeling more hopeful (83%) and as having more control over their disease (63%). Men with prostate cancer had strong beliefs about the potential for CAM to successfully treat their disease. Ninety percent believed it would help them live longer and improve quality of life, and 47% expected CAM to cure their disease. 2 Control was also identified as an important theme in the decision to forgo treatment in Montbriand's 7 qualitative study with cancer patients who abandoned conventional treatment. A qualitative study by Verhoef and White presented a framework for factors influencing the decision to forgo conventional cancer treatment in which control was identified as an important theme. 8 Men with prostate cancer emerged as a distinct group in the degree to which they took control over all aspects of their cancer care and in their motivation to involve their physicians in a way that integrated their decision making about conventional and complementary therapies. Our previous research allows the opportunity to further explore this issue. 8 We reanalyzed the data on patients with prostate cancer to explore in depth how sense of control was related to the decision to forgo conventional treatment for prostate cancer and to use CAM therapies for their cancer.
Methods
This article draws on the data from our qualitative study of cancer patients who refused one or more conventional cancer treatments. Thirty-one patients in Vancouver (British Columbia) and Calgary (Alberta) participated in the study. Factors that influenced the decision to delay or forgo conventional treatment include predisposing factors (traumatic childhood illness, family history of cancer, health beliefs, and decision-making control); patient-doctor communication; information-seeking; and social referents (eg, natural health care providers, family members). The complete findings and description of the data collection methods are reported elsewhere. 8 In the current analysis, transcripts for the 8 patients with prostate cancer were analyzed separately. Each transcript was analyzed line-by-line and coded according to the factors that link decision-making control to the decision to forgo conventional treatment. The authors independently reviewed the transcripts and met to discuss themes and resolve areas of discrepancy. Background data on personal and medical characteristics are included in Table 1 .
Results
Fear was the overriding response to being informed about a diagnosis of prostate cancer. Participants repeatedly used the word "scared" to describe their response to a cancer diagnosis. Fears were intensified by a poor prognosis, anxieties about medical procedures, and perceived severity of treatment side effects. Fear seemed to act as a catalyst for the men in this study to take control over treatment decision making and seek alternative therapies instead of following the recommendation of their cancer specialist. Five thematic areas were identified in which patients took control, in the context of their decision to forgo conventional treatment: (1) the timing of treatment, (2) information about conventional treatment and risk assessment, (3) designing an alternative treatment plan, (4) coordination of cancer care, and (5) monitoring and evaluation of disease progression.
Control Over the Timing of Treatment
Several men responded to their diagnosis by taking control over the timing of the decision about when to have conventional treatment. Some felt that the doctor was pushing them too fast to make a treatment decision:
Well, it seemed that they just wanted to push it on too fast . . . so I thought, no I will see what else I can find . . . 
Control Over Information About Conventional Treatment and Risk Assessment
Fear of treatment side effects such as impotence, incontinence, and a cancer recurrence acted as a catalyst for men to seek increased control over information seeking about side effects in response to the feeling that their specialists were minimizing the impact of treatment on their quality of life.
And I felt that the traditional medical people took it very lightly. . . . The first oncologist I went to described [incontinence] to me as a minor inconvenience whereas to me peeing your pants is a major inconvenience. (Patient 1) But what he didn't explain to me [was] how he was going to alleviate the after effects of the surgery. . . . He kind of blew it off and said, "Well, we'll take care of that. Let's get it out first." (Patient 2) Men searched for treatment information through books, the Internet, and support groups, and consulted health care providers and other cancer specialists. They used this information to conduct their own risk assessment of conventional treatment, independent of the oncologist: In some cases, information seeking increased concerns about the potential risks of treatment. The conflicting opinions between other sources of information and information obtained from the specialist reinforced their perception that the doctor was holding back information:
Dr.
[X] assured me that incontinence wasn't a problem with radiation. That he had never seen that. Yet I had read in numerous books that it was a problem. (Patient 5) Conflicting information was particularly the case for radiation therapy as men found information that reinforced their fear that their cancer would recur if they had radiation therapy. This information had a direct impact on the decision to forgo radiation therapy:
After reading all the side effects of all the radiation . . .
[I] delayed it. And I asked people . . . and they say, "Oh my cancer came back after radiation." . . . . Then what's the use of taking something that will come back? (Patient 3) So they sent me to an oncologist and of course then it's "take my radiation" . . . and even with it he said, "You've got 6 months to 2 years, at tops" . . . and that was after I got a whole bunch of notes here on how this great radiation will help kill you. And he wouldn't deny it. (Patient 6) One patient researched the additional risks he may face due to a childhood illness. He took control by conducting his own diagnosis and risk assessment. He learned that this might increase his risk of complications from surgery. This additional information played a significant role in his decision to avoid surgery. 
Decision-Making Control

Control Over Designing an Alternate Treatment Plan
The desire to avoid side effects of conventional treatment acted as a catalyst for men to thoroughly investigate alternative therapies. Some men designed a treatment program based on their holistic health beliefs, whereas others searched for alternative therapies that had fewer side effects. Some men described their role in their cancer care as "being their own doctor": Most of the men learned about complementary therapies after their diagnosis. They engaged in thorough research about alternative therapies and designed an alternate treatment plan. For example, one person's plan included a strict organic diet, 3 weekly injections of a multiple respiratory vaccine, naltrexone, 35-day cesium therapy, and IV treatment from the naturopath. He had started on hormone therapy but discontinued treatment after 2 months. Two men were committed to holistic health prior to their diagnosis of cancer. Their decision to forgo conventional treatment was based on the belief that they could control their cancer through holistic health practices. One patient used an intensive mind-body approach that integrated psychological and meditative techniques with natural health supplements. He describes his experience using visualization to confront and gain control over the cancer: I started to say I am healing myself in 6 months . . . I was doing between 5 and 14 hours of meditation and visualization a day . . . I started to view myself and when the cancer cells are face to face there is a big fight and after 3 months there was this big fight . . . I was so sick . . . and I thought maybe I will go for the operation but I said I will keep going . . . after 2 or 3 weeks . . . the immune system was getting stronger and stronger . . . and the cancer started to disappear. (Patient 4) The other participant was a natural health care practitioner for most of his life. He used traditional Chinese medicine, yoga, acupuncture, and diet to treat his cancer. His decision to treat his cancer holistically was based on his faith in God, and in his need to teach others about natural healing practices. He presented his decision to refuse conventional treatment in the context of relinquishing control to a higher spiritual power.
The doctors believe in what they do. Now I believe that God can help and nothing is impossible to him. I sacrifice myself instead of relying on the medical field, or radiation . . . he says, oh 90% you will get well. But so I do my own way. See, if I do get well, I can tell more people, at the same time I'm trying to bring man to God. I'm using myself as a stepping-stone. (Patient 3)
Patients chose to define evidence differently than their doctors, in deciding which therapies to use to treat their cancer. Although most conducted extensive research into the products they were using, the advice and experience of neighbors, family, and friends also had an impact on their decision to refuse conventional treatment:
It was kind of just fortuitous that I'm going for this biopsy and the landlord says . . . "Chinese medicine in Seattle." He says, "don't have the surgery. Chinese medicines are doing wonders with prostate cancer and let me get you these guys' names and talk to them before you do it. Finally, some men gathered information from alternate health care providers to share with their cancer specialists, in an effort to have integrated care and involve the specialist in evaluating the alternative therapy they were using.
Control Over Monitoring and Evaluation of Disease Progression
All patients were having regular PSA blood tests to monitor their disease progression. A specialist, a family doctor, and/or a natural health practitioner followed patients. Some men encouraged and valued the involvement of their specialist in the evaluation of the alternative approaches they were trying: Yes. I told him, I just want to delay . . . want to see my own way to see what happens, but he says, well, if you don't now, I won't treat you no more. And I know the medical profession is supposed to swear that they are going to help mankind. (Patient 3) The PSA test was an important factor for men wanting to take control over their treatment choices. It provided them with a straightforward way to monitor the effectiveness of the alternative approaches they were trying. This provided a sense of safety to explore treatment alternatives:
If it wasn't for that [PSA], I think I would have the surgery probably right away. I mean . . . you've got no choice. (Patient 2) Some men set their own timelines for when to evaluate the alternative approaches they were trying. The PSA blood test provided them with information they needed to decide whether to continue with alternative treatments.
When I first got the PC-SPES, the naturopath said, "Let's give it 10 days." So I thought, "Well, it's 10 days, a couple hundred bucks, I got nothing to lose.?" When it went down . . . from 22 to 14 in 10 days, to me . . . that's okay. (Patient 1) In some cases, patients wanted more control over the timing and number of PSA tests than their specialist thought necessary. Some men paid for additional PSA tests through their naturopath to evaluate their disease progress: I was at the naturopath and he took [the] PSA and scheduled an appointment next week for some more tests. I tried to have most of my PSA tests through the urologist and he has been pretty good about it until this last one . . . because they're free Most of the men in this study perceived they had brought their cancer under control with the alternative approach they were using. Four were certain the treatment plan they had designed had cured their cancer. chose to see his family doctor for follow-up care. He reported that his cancer is considered to be in remission.
It took me 5½ months to heal and a year to clean the blood. After a year and a half, I went back to my family doctor and I said take all the exams you want and she said yeah it's probably in remission. (Patient 4) Two others were cautiously optimistic that their disease was under control, based on declining PSA levels. These 2 patients felt they had conducted sufficient research, tried alternative approaches, and were emotionally prepared to accept conventional treatment, should their PSA levels increase.
The hormones took my PSA from 15 down to 1.0 and then in the last month, doing the alternative therapy, it has gone down to 0.05 and needless to say I am optimistic that it is working . . . at the first sign of things going out of control, I'll be back at the oncologist's office. (Patient 1)
Discussion and Clinical Implications
This article draws on the data collected for a small sample of patients to examine control in relation to the decision to forgo conventional treatment for prostate cancer. Although small, the study provides new insights that have not been previously highlighted. The findings suggest that taking control over all aspects of cancer care was motivated by fear and anxiety about treatment side effects, a desire for integrated cancer care, and needing time to adjust to the diagnosis. The theoretical insight that taking control over decision making is a coping response to fear and anxiety at diagnosis needs to be explored further in a larger study. The men with prostate cancer in this study increased their sense of control by setting their own timelines, information seeking, designing an alternative treatment plan, and controlling the monitoring of disease status. Most men were newly diagnosed and had a favorable prognosis with conventional treatment. In spite of this, they were choosing to forgo conventional cancer treatment in favor of alternative approaches. All were using the PSA blood test to evaluate their disease status, and most reported their PSA levels were falling. It was their perception that this was due to the effectiveness of the alternative therapies they were using.
These findings suggest psychosocial factors play an important role in the decision to forgo conventional treatment for prostate cancer. First, most participants experienced considerable distress at diagnosis and after the consultation about treatment options. The role of mental distress in dissatisfaction with treatment decision making 9 and consultation with CAM providers 10 has been documented in other studies. The patients in this study appeared to respond to their distress by taking control over designing their own treatment plan. They turned to natural care providers and family as sources of information and support. Risberg et al 11 suggested that the tendency of CAM users to take advice from family and friends over doctors may be a strategy for coping with malignant disease in family life. Turning to other sources for support may also be because their emotional needs were not adequately addressed at diagnosis. Crawford et al's 12 matched study found that patients rate cancer specialists as not doing an adequate job at referring prostate cancer patients to emotional support programs.
Second, fears related to treatment side effects influenced the decision to forgo conventional treatment. This study identifies 2 fears related to side effects that influenced patients to decline conventional treatment. Fear of recurrence was identified as 1 reason for refusing radiation therapy. Some patients expressed a sense of fatalism about radiation treatment. It was their perception that they would eventually die from the effects of the radiation, based on information they had read and/or on anecdotal reports of other patients. Long 13 found in her qualitative study that cancer patients' fears remained with them throughout radiation treatment when health professionals did not adequately address misconceptions. Fear about loss of sexual function was also a motivating factor for men to forgo surgery and seek alternative approaches with less invasive side effects. Heikkila et al's 14 study on gender and treatment choices by patients undergoing coronary arteriography found that men experienced more intensive fear of problems related to their sex life than do women. Some men in our study said their specialist was minimizing the impact that impotence would have on their quality of life. A matched study by Crawford et al 12 reported different treatment goals for the urologist and the patient. The patient's goal for treatment emphasized preservation of quality of life (45%), whereas the physician's primary goal was treatment efficacy (86%).
Third, the need to maintain decision-making control was very important for patients in this study. A high preference for control over treatment decision making has been documented as being characteristic of men with prostate cancer. 15, 16 Prostate patients in this study had an even higher preference for decisionmaking control (Table 1 ) than in the published data. 16 Most patients expressed feeling rushed into treatment decisions, and they wanted control over the timelines for their decisions about surgery. Some patients placed a high value on their specialist's continued involvement in their treatment decisions, as long as the patient remained in control of the timing of the decision. The degree of involvement seemed to depend on how the physician responded to the patient's decision to delay treatment and try alternative approaches. The need for involvement in decision making has been identified as a key motivating factor for CAM use, 17 as is the need to maintain a sense of control. 1, 2, 17 Some patients communicated openly with their specialists about the alternative approaches they were trying. Others reported negative reactions by their physicians, which resulted in them minimizing or discontinuing contact with their specialist. In a study exploring barriers to communication about CAM use, many patients reported their doctors responded negatively to their disclosure of CAM use, with reactions ranging from hidden disapproval to active opposition. 18 There are several clinical implications of this research in relation to unmet needs for information and support. Two studies on CAM use by cancer patients caution that the desire to use or discuss CAM may be a signal that there are unmet needs elsewhere. 2, 18 First, men with prostate cancer who forgo conventional treatment expressed a need for time and support to make the emotional adjustment to a cancer diagnosis. Addressing psychosocial distress early in the decision-making process may shorten the time some patients delay conventional treatment. Wilkinson et al 2 suggest that CAM use may help identify patients who are having difficulty adjusting to the threat of cancer. They recommend that physicians encourage prostate patients who are using CAM to discuss feelings of fear, anxiety, and depression. Second, fears of recurrence related to radiation treatment and concerns about the impact of treatment on sexuality and relationships should be fully explored early on in the decision-making process. Long 13 advises that providing better information and preparation about what to expect from radiation treatment may increase a patient's sense of control. Third, most patients expressed the need to communicate openly with their physicians about the alternative approaches they were using. Tasaki et al 18 outline physician guidelines to promote open communication with patients about CAM. Physicians may also need information and education about CAM therapies to assist patients to make informed decisions. Fourth, patients sought a high degree of control over decision making and turned away from physicians whose reactions diminished their sense of control. The Ullrich-Hodge Alternative Therapy Model 17 provides a more formal framework for health care providers to assess the use of CAM with patients in a nonthreatening way that maintains the patient's sense of control over decision making.
Delaying conventional treatment to use only complementary therapies for prostate cancer involves the risk that the cancer may progress. The Ullrich-Hodge Alternative Therapy Model describes a process for assessing risk associated with the use of CAM and for finding collaborative solutions that involve the patient in decision making and is consistent with his or her belief system. Encouraging patients to keep copies of and distribute test results to both complementary and conventional care providers may also increase sense of control and improve communication between providers. Norum 19 found that providing patients with a copy of their medical report from an outpatient visit with their medical oncologist was beneficial to almost all patients. Finally, health care providers can support prostate patients who are delaying or refusing treatment by encouraging their efforts to develop an integrated care plan that incorporates the patient's spiritual beliefs. By respecting the role of spiritual beliefs in the formation of treatment choices, patients can develop a care plan consistent with their philosophy of healing.
The themes that emerged in this study need to be evaluated in a systematic and quantitative manner with a larger sample of patients. We have recently been funded by Health Canada to conduct a 5-year longitudinal study to assess factors influencing the decision to forgo conventional treatment for men with prostate cancer. The study will assess changes in psychosocial outcomes, quality of life, treatment decision making, and disease status over a 3-year period.
In summary, health professionals can support prostate patients who delay or forgo treatment by increasing their sense of control over the decision-making process, addressing fears underlying treatment decisions, responding to unmet needs for information and emotional support, and encouraging their efforts to integrate their conventional and complementary care.
